TriNetX Uses AI and Real-World Data to Shrink Clinical Trial Timelines
The company announced new results showing that its TriNetX LIVE™ platform—which combines clinically rich real-world data (RWD) with artificial intelligence—is materially improving how pharmaceutical companies design and execute clinical trials. The results aren’t theoretical: fewer protocol amendments, faster site identification, and more efficient recruitment are already shaping how sponsors plan studies.
